Gainers & Losers
Fri Jan 16 2026 10:20:19- Infosys share price
- ₹1,689.405.65%
- Tech Mahindra share price
- ₹1,670.555.17%
- Tata Consultancy Services share price
- ₹3,206.701.92%
- HCL Technologies share price
- ₹1,698.901.82%
- State Bank of India share price
- ₹1,042.301.36%
Active Stocks
Fri Jan 16 2026 10:29:29- Yes Bank share price
- ₹23.462.22%
- Suzlon Energy share price
- ₹48.50-1.04%
- Kotak Mahindra Bank share price
- ₹418.25-0.65%
- Indus Towers share price
- ₹434.00-0.98%
- Federal Bank share price
- ₹270.359.50%
Aarti Pharmalabs Profit & Loss Annual
803.85 +10.80 (1.36%)Updated : 16 Jan 2026
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 1,737.61 | 1,539.80 | 1,665.33 | 879.35 |
| Other Net | 0.04 | 0.60 | -1.23 | -11.61 |
| Diluted Weighted Average Shares | 9.06 | 9.06 | 9.06 | 9.06 |
| Gain( Loss)on Saleof Assets | 0.01 | 0.02 | -0.45 | -155.75 |
| Depreciation/ Amortization | 86.90 | 73.24 | 62.54 | 42.12 |
| Operating Income | 377.47 | 312.81 | 279.90 | 320.59 |
| Net Income | 272.40 | 216.90 | 193.49 | 122.25 |
| Income Availableto Com Excl Extra Ord | 272.40 | 216.90 | 193.49 | 122.25 |
| Other Operating Expenses Total | 0.00 | 0.00 | 3.65 | -0.94 |
| Net Income Before Taxes | 360.69 | 300.49 | 260.77 | 155.38 |
| Net Income After Taxes | 272.40 | 216.90 | 193.49 | 122.25 |
| Income Availableto Com Incl Extra Ord | 272.40 | 216.90 | 193.49 | 122.25 |
| Costof Revenue Total | 1,127.88 | 1,020.72 | 1,169.76 | 725.11 |
| Gross Profit | 987.20 | 831.89 | 775.48 | 474.84 |
| Interest Inc( Exp) Net- Non- Op Total | -16.82 | -12.94 | -17.45 | 2.14 |
| Diluted Net Income | 272.40 | 216.90 | 193.49 | 122.25 |
| DPS- Common Stock Primary Issue | 5.00 | 3.00 | - | 0.00 |
| Provisionfor Income Taxes | 88.28 | 83.59 | 67.28 | 33.13 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 272.40 | 216.90 | 193.49 | 122.25 |
| Total Revenue | 2,115.07 | 1,852.61 | 1,945.23 | 1,199.94 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 2,115.07 | 1,852.61 | 1,945.23 | 1,199.94 |
| Selling/ General/ Admin Expenses Total | 489.99 | 437.48 | 415.43 | 107.25 |
| Diluted Normalized EPS | 30.05 | 23.93 | 21.39 | 27.01 |
| Research Development | 32.83 | 8.37 | 13.96 | 5.82 |
| Diluted EPS Excluding Extra Ord Items | 30.06 | 23.93 | 21.35 | 13.49 |
| Unusual Expense( Income) | - | - | 0.00 | - |
*All figures in crores except per share values
Aarti Pharmalabs Quick Links
Aarti Pharmalabs Dividend Aarti Pharmalabs Bonus Aarti Pharmalabs News Aarti Pharmalabs AGM Aarti Pharmalabs Rights Aarti Pharmalabs Splits Aarti Pharmalabs Board Meetings Aarti Pharmalabs Key Metrics Aarti Pharmalabs Shareholdings Aarti Pharmalabs Balance Sheet Aarti Pharmalabs Cashflow Aarti Pharmalabs Q1 Results Aarti Pharmalabs Q2 Results Aarti Pharmalabs Q3 Results Aarti Pharmalabs Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
1,690.90+91.85(5.74%)
1,671.00+82.50(5.19%)
3,209.40+63.10(2.01%)
287.45-11.75 (-3.93%)
2,752.00-63.35 (-2.25%)